Shared posts

21 Feb 09:25

COF-based artificial probiotic for modulation of gut microbiota and immune microenvironment in inflammatory bowel disease

by Qingqing Deng

Chem Sci. 2022 Dec 27;14(6):1598-1605. doi: 10.1039/d2sc04984h. eCollection 2023 Feb 8.

ABSTRACT

Conventional strategies for treating inflammatory bowel disease merely relieve inflammation and excessive immune response, but fail to solve the underlying causes of IBD, such as disrupted gut microbiota and intestinal barrier. Recently, natural probiotics have shown tremendous potential for the treatment of IBD. However, probiotics are not recommended for IBD patients, as they may cause bacteremia or sepsis. Herein, for the first time, we constructed artificial probiotics (Aprobiotics) based on artificial enzyme-dispersed covalent organic frameworks (COFs) as the "organelle" and a yeast shell as the membrane of the Aprobiotics to manage IBD. The COF-based artificial probiotics, with the function of natural probiotics, could markedly relieve IBD by modulating the gut microbiota, suppressing intestinal inflammation, protecting the intestinal epithelial cells, and regulating immunity. This nature-inspired approach may aid in the design of more artificial systems for the treatment of various incurable diseases, such as multidrug-resistant bacterial infection, cancer, and others.

PMID:36794177 | PMC:PMC9906670 | DOI:10.1039/d2sc04984h

07 Oct 05:09

KAT6A Acetylation of SMAD3 Regulates Myeloid‐Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple‐Negative Breast Cancer

by Bo Yu, Fei Luo, Bowen Sun, Wenxue Liu, Qiqi Shi, Shi‐Yuan Cheng, Ceshi Chen, Guoqiang Chen, Yanxin Li, Haizhong Feng
KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer

TGF-β1 potentiates KAT6A acetylation of SMAD3 at K20 and K117, which promotes SMAD3 association with oncogenic H3K23ac reader tripartite motif-containing 24 (TRIM24) and thereby increases SMAD3 transcriptional activation. Activated SMAD3 upregulates immune-related cytokines, leading to enhanced breast cancer stem-like cell properties, myeloid-derived suppressor cell (MDSC) recruitment, and triple-negative breast cancer (TNBC) metastasis. Targeting KAT6A improves the anticancer metastasis efficacy of anti-PD-L1 therapy.


Abstract

Aberrant SMAD3 activation has been implicated as a driving event in cancer metastasis, yet the underlying mechanisms are still elusive. Here, SMAD3 is identified as a nonhistone substrate of lysine acetyltransferase 6A (KAT6A). The acetylation of SMAD3 at K20 and K117 by KAT6A promotes SMAD3 association with oncogenic chromatin modifier tripartite motif-containing 24 (TRIM24) and disrupts SMAD3 interaction with tumor suppressor TRIM33. This event in turn promotes KAT6A-acetylated H3K23-mediated recruitment of TRIM24–SMAD3 complex to chromatin and thereby increases SMAD3 activation and immune response-related cytokine expression, leading to enhanced breast cancer stem-like cell stemness, myeloid-derived suppressor cell (MDSC) recruitment, and triple-negative breast cancer (TNBC) metastasis. Inhibiting KAT6A in combination with anti-PD-L1 therapy in treating TNBC xenograft-bearing animals markedly attenuates metastasis and provides a significant survival benefit. Thus, the work presents a KAT6A acetylation-dependent regulatory mechanism governing SMAD3 oncogenic function and provides insight into how targeting an epigenetic factor with immunotherapies enhances the antimetastasis efficacy.

07 Oct 05:06

Therapeutic inhibition of USP9x-mediated Notch signaling in triple-negative breast cancer [Medical Sciences]

by Arushi Jaiswal, Kiichi Murakami, Andrew Elia, Yukiko Shibahara, Susan J. Done, Stephen A. Wood, Nicholas J. Donato, Pamela S. Ohashi, Michael Reedijk
Triple-negative breast cancer (TNBC) is a breast cancer subtype that lacks targeted treatment options. The activation of the Notch developmental signaling pathway, which is a feature of TNBC, results in the secretion of proinflammatory cytokines and the recruitment of protumoral macrophages to the tumor microenvironment. While the Notch pathway is...
29 Jun 11:49

[ASAP] Aligned Ti3C2Tx MXene for 3D Micropatterning via Additive Manufacturing

by Sayli Jambhulkar, Siying Liu, Pruthviraj Vala, Weiheng Xu, Dharneedar Ravichandran, Yuxiang Zhu, Kun Bi, Qiong Nian, Xiangfan Chen, and Kenan Song

TOC Graphic

ACS Nano
DOI: 10.1021/acsnano.1c03388